HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98% HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98%
GFS GFSGayatri Financial Synergy
/
Client Login
GFS » Mutual Fund » Sectoral / Thematic » DSP Healthcare Fund
Published NAVNAV published by the AMC, sourced from AMFI
7.2822.7638.2453.733 Dec 201820 Aug 2026
Change+409.6%change over the window — not annualised
Low / high₹9.77 / ₹51.2420 Jun 2019 · 20 Aug 2026
Last print+0.14%19 Aug 2026 → 20 Aug 2026
Prints974published NAVs, AMFI · axis does not start at zero

Returns

NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W +0.35%
1M +3.83%
3M +12%
6M +23.7%
YTD +17.7%
1Y +16.33%
2Y CAGR +10.97%
3Y CAGR +22.22%
5Y CAGR +16.5%
10Y CAGR
SIP · XIRR on monthly instalments
6M SIP +67.12%
1Y SIP +33%
2Y SIP +17.01%
3Y SIP +18.65%
5Y SIP +20.75%
10Y SIP
Full history SIP +22.75%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.

Returns vs category

1Y
This fund
+16.33%
Sectoral / Thematic avg
+9.11%
3Y
This fund
+22.22%
Sectoral / Thematic avg
+17.01%
5Y
This fund
+16.5%
Sectoral / Thematic avg
+14.93%
Average is the mean of every Sectoral/ Thematic scheme in this dataset that discloses the period — 216 schemes at 1Y, 126 at 3Y, 94 at 5Y. Returns beyond one year are annualised.

Top holdings

as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
Sun Pharmaceutical Industries LtdPharmaceuticals & Biotechnology 8.42%
IPCA Laboratories LtdPharmaceuticals & Biotechnology 8.17%
Cipla LtdPharmaceuticals & Biotechnology 8.13%
Sai Life Sciences LtdPharmaceuticals & Biotechnology 7.1%
Gland Pharma LtdPharmaceuticals & Biotechnology 6.35%
Apollo Hospitals Enterprise LtdHealthcare Services 5.81%
Globus Medical IncHealthcare Equipment & Supplies 5.57%
Alkem Laboratories LtdPharmaceuticals & Biotechnology 4.66%
Cohance Lifesciences LtdPharmaceuticals & Biotechnology 3.75%
Vijaya Diagnostic Centre LtdHealthcare Services 3.47%
Top 10 61.43%Securities 30Securities total 93.54%Cash & equivalents 6.46%
The ten largest securities by weight, out of 30 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.

Risk

Volatility · annualised · 3Y
13.89%
Max drawdown · 3Y
-16.09%
Sharpe ratio
1.04
SEBI riskometer
Very High
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed.
Beta and alpha are not shown. No benchmark series in the source.

Cost

Expense ratio0.71%
Category average1.73%
Exit load0.5%
52W high / low₹51.237 / ₹39.918
Expense ratio 0.71% vs a category average of 1.73% — 1.02 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 5th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.

Scheme facts

SEBI sub-category Sectoral/ Thematic
Plan / option Direct Growth
Benchmark BSE Health Care - TRI
Fund manager Chirag Dagli
Launched 12 Nov 2018
NAV history here 7.7y
ISIN INF740KA1LG1
AMFI scheme code 145454
SEBI riskometer Very High
Exit load 0.5%
Lock-in None
Minimum lumpsum ₹100
Exit load, as disclosed: 0.50% on or before 1M · Nil after 1M
Not shown on this page, and why
Star ratingGFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUMScheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIPNot present in the source.
Beta and alphaNo benchmark series in the source.

General SIP calculator

A general SIP illustration: your monthly amount grown at the annual rate you set below, compounded monthly. The rate is your assumption — it is not this scheme’s past return, not a forecast of it, and mutual fund returns are not assured.
Monthly SIP₹10,000
Tenure10 years
Assumed annual return12%
Invested₹12,00,000
Est. gain₹11,23,391
Total value₹23,23,391